Sampling
The study center was a tertiary referral cancer center. Sample size estimates of around 100 to 200 patients were used, assuming 15% to 20% of all referrals received EOL decisions and limitations of treatment (based on previously published data) and a service seeing approximately 1000 patients a year. Table 1 outlines inclusion/exclusion criteria.